[1] 庞秀贤. Ⅰ型子宫内膜癌与代谢综合征的高危因素相关性研究[D]. 南昌:南昌大学, 2021.
[2] Jiang X, Tang H, Chen T.Epidemiology of gynecologic cancers in China[J]. J Gynecol Oncol, 2018, 29(1): e7.
[3] Bray F, dos Santos Silva I, Moller H, et al. Endometrial cancer incidence trends in Europe: Underlying determinants and prospects for prevention[J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(5): 1132-1142.
[4] Dou Y, Kawaler EA, Zhou DC, et al. Proteogenomic characterization of endometrial carcinoma[J]. Cell, 2020, 180(4): 729-748. e26.
[5] Onstad MA, Schmandt RE, Lu KH.Addressing the role of obesity in endometrial cancer risk, prevention, and treatment[J]. J Clin Oncol. 2016, 34(35): 4225-4230.
[6] Ng M, Fleming T, Robinson M, et al.Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2014, 384(9945): 766-781.
[7] 张心,王建东.子宫内膜癌相关流行病学高危因素的研究进展[J].医学综述, 2021, 27(15): 2995-2999.
[8] Jemal A, Bray F, Center MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61(2): 69-90.
[9] Boll D, Verhoeven RH, van der Aa MA, et al.Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands[J]. Cancer, 2012, 445(9): 599-606.
[10] Anderson AS, Key TJ, Norat T, et al, European code against cancer 4th edition: Obesity, body fatness and cancer[J].Cancer Epidemiol, 2015, 39(1): 181-188.
[11] MacKintosh ML, Crosbie EJ. Prevention strategies in endometrial carcinoma[J]. Current Oncology Reports, 2018, 20(12): 1-8.
[12] Li MY.Prognostic factors of endometrial carcinoma: An, analysis of 171 cases[J].J Chin Oncol, 2016, 22(7): 543-548.
[13] Wartko P, Sherman ME, Yang HP, et al.Recent changes in endometrial cancer trends among menopausal-age US women[J]. Cancer Epidemiol, 2013, 37(4): 374-377.
[14] Chen W, Zheng R, Zhang S, et al.Cancer incidence and mortality in China, 2013[J]. Cancer Lett,2017, 401: 63-71.
[15] 杨曦, 廖秦平. 子宫内膜癌筛查的现状及研究进展[J]. 中国实用妇科与产科杂志, 2021, 37(12): 1269-1272.
[16] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66(2): 115-132.
[17] Gonthier C,Trefoux-Bourdet A, Koskas M.Impact of conservative managements in young women mth grade 2 or 3 endometrial adenocarcinoma confined to the endometrium[J]. Int J Gynecol Cancer, 2017, 27(3): 493-499.
[18] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30.
[19] Smith RA,Andrews KS,Brooks D,et al.Cancer screening in the United States, 2018:A review of current American Cancer Society guidelines and current issues in cancer screening[J].CA Cancer J Clin, 2018, 68(4): 297-316.
[20] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2019[J]. CA Cancer J Clin, 2019,69(1): 7-34.
[21] Gentry-Maharaj A, Karpinskyj C.Current and future approaches to screening for endometrial cancer[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 65(5): 79-97.
[22] Robertson G.Screening for endometrial cancer[J]. Lancet, 2005, 366(9484): 494-505.
[23] Chao X, Li L, Wu M, et al.Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: A prospective cohort study in China[J]. Cancer Commun (Lond), 2019, 39(1): 42.
[24] 赵冬旭, 李安沣, 高佳音, 等. 宫颈癌早期筛查方法研究进展[J]. 中国优生与遗传杂志, 2021, 29(4): 440-443.
[25] McCluggage WG. Pathologic staging of endometrial carcinomas: selected areas of difficulty[J]. Adv Anat Pathol, 2018, 25(2): 71-84.
[26] Huvila J, Pors J, Thompson EF, et al.Endometrial carcinoma: Molecular subtypes, precursors and the role of pathology in early diagnosis[J]. J Pathol, 2021, 253(4): 355-365.
[27] McAlpine J, Leon‐Castillo A, Bosse T. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses[J]. J Pathol, 2018, 244(5): 538-549.
[28] Lortet-Tieulent J, Ferlay J, Bray F, et al.International patterns and trends in endometrial cancer incidence, 1978-2013[J]. J Natl Cancer Inst, 2018, 110(4): 354-361.
[29] 曾艳华. 子宫内膜癌患病的危险因素Logistic回归分析[J]. 中国妇幼保健, 2012, 35(27): 5691-5694.
[30] 姜娜. 鲁北地区子宫内膜癌发病因素病例对照研究[J]. 中华肿瘤防治杂志, 2013, 20(19):1469-1472.
[31] Lindemann K, Vatten LJ, Ellstrm Engh M, et al.Bodymass, diabetesand smoking and endometrial cancer risk a follow up study[J]. Br J Cancer, 2008,98(9):1582-1585.
[32] Onstad MA, Schmandt RE, Lu KH.Addressing the role of obesity in endometrial cancer risk, prevention, and treatment[J]. J Clin Oncol, 2016, 34(35): 4225-4230.
[33] 李楠. 子宫内膜癌高危因素的Meta分析[D].长春:吉林大学,2014.
[34] Bodurtha Smith AJ, Fader AN, Tanner EJ,et al.Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2017, 92(2): 459-476. |
粤公网安备 44011302000297号 